Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,985,483 papers from all fields of science
Search
Sign In
Create Free Account
22q13.3 Deletion Syndrome
Known as:
PHELAN-MCDERMID SYNDROME
, Telomeric 22q13 Monosomy Syndrome
, Deletion 22q13 Syndrome
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
16 relations
Aggressive behavior
Blepharoptosis
Global developmental delay
Long narrow head
Expand
Broader (3)
Chromosome Deletion
Chromosomes, Human, Pair 22
Congenital chromosomal disease
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
sp3-Bonded silicon allotropes based on the Kelvin problem.
Hui-Yan Zhao
,
Jing Wang
,
Qingmin Ma
,
Y. Liu
Physical Chemistry, Chemical Physics - PCCP
2013
Corpus ID: 24933548
The Kelvin problem, how to partition three-dimensional space into cells of equal volume with minimal area, is a fascinating one…
Expand
2011
2011
A translocation between Xq21.33 and 22q13.33 causes an intragenic SHANK3 deletion in a woman with Phelan–McDermid syndrome and hypergonadotropic hypogonadism
D. Misceo
,
O. Rødningen
,
+8 authors
Eirik Frengen
American Journal of Medical Genetics. Part A
2011
Corpus ID: 205313840
Chromosome 22q13 monosomy has been described as a contiguous gene syndrome. Localized in the critical region, SHANK3 is likely to…
Expand
2010
2010
A de novo 7.9 Mb deletion in 22q13.2→qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings.
Chih-ping Chen
,
Shuan-Pei Lin
,
+6 authors
Wayseen Wang
European Journal of Medical Genetics
2010
Corpus ID: 29198801
2009
2009
Fulminant autoimmune hepatitis in a girl with 22q13 deletion syndrome: a previously unreported association
M. Tufano
,
C. Della Corte
,
+5 authors
R. Iorio
European Journal of Pediatrics
2009
Corpus ID: 23417986
We report a 7-year-old girl with 22q13 deletion syndrome, 46,XX,Ish del(22)(q13.3)(ARSA-; D22S1726), who developed a fulminant…
Expand
2005
2005
Two brothers with 22q13 deletion syndrome and features suggestive of the Clark–Baraitser syndrome
E. Tabolacci
,
M. Zollino
,
+5 authors
G. Neri
Clinical Dysmorphology
2005
Corpus ID: 19949434
We report on two brothers with moderate-to-severe mental retardation, severe macrocephaly, obesity, characteristic face, big…
Expand
Review
2004
Review
2004
22q13 Deletion Syndrome: An Update and Review for the Primary Pediatrician
J. Havens
,
J. Visootsak
,
M. C. Phelan
,
J. Graham
La Clinica pediatrica
2004
Corpus ID: 7193195
Recent advances in genetic testing can help to provide a specific diagnosis to children born with syndromes that result in…
Expand
2004
2004
22q13 deletion syndrome with central diabetes insipidus: a previously unreported association.
A. Barakat
,
P. Pearl
,
M. Acosta
,
B. Runkle
Clinical Dysmorphology
2004
Corpus ID: 17017168
We describe a two-year-old girl with 22q13 deletion syndrome (MIM # 606232), 46, XX, de l (22) (q13.31). ish del (22) (q13.31…
Expand
2000
2000
Cryptic subtelomeric translocations in the 22q13 deletion syndrome
V. Praphanphoj
,
B. Goodman
,
G. Thomas
,
G. Raymond
Journal of Medical Genetics
2000
Corpus ID: 13805342
Cryptic subtelomeric rearrangements are suspected to underlie a substantial portion of terminal chromosomal deletions. We have…
Expand
1997
1997
A COMPARISON OF WIND TUNNEL AND CFD METHODS APPLIED TO NATURAL VENTILATION DESIGN
D. Alexander
,
H. Jenkins
,
P. Jones
,
Welsh
1997
Corpus ID: 16109584
The design of a naturally ventilated atrium was assessed using both wind tunnel and CFD methods to appraise and modify the…
Expand
1996
1996
Comparing the Weaire-phelan Equal-volume Foam To
J. Sullivan
1996
Corpus ID: 18558691
The problem of partitioning space into equal-volume cells, using the least interface area, was considered in 1887 by Sir William…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE